Ghani ChemWorld Limited Records Financial Loss in Initial Reporting Period

Lahore: Ghani ChemWorld Limited, a subsidiary of Ghani Chemical Industries Limited, has reported its financial results for the period from its incorporation on July 31, 2024, to February 20, 2025, revealing a loss after taxation of 237.39 million. The financial statements were reviewed under the International Standard on Review Engagements (ISRE) 2400 (Revised) and prepared in accordance with the International Financial Reporting Standards.

The company's statement of financial position as of February 20, 2025, shows total assets amounting to 265.95 million. Detailed in the report are non-current assets and current assets, which include advance income tax, loans and advances, as well as cash and bank balances. The equity and liabilities section highlights an authorized share capital of 1 billion, with 500 million issued, subscribed, and paid-up share capital. Accumulated losses stand at 237.39 million, culminating in total equity and liabilities of 265.95 million. Current liabilities include other payables amounting to 3.34 million.

According to information available from the Pakistan Stock Exchange (PSX), the company's financial performance for the period resulted in a gross loss after accounting for administrative and general expenses of 237.44 million. The financial results further indicate a marginal other income of 48,000, with no tax expenses reported, leading to a final loss before and after taxation of 237.39 million. The loss per share, both basic and diluted, is calculated at 4.75.

The review, executed in line with ISRE 2400 (Revised), involved inquiries and analytical procedures to provide limited assurance on the financial statements. The conclusion from the review indicates no material misstatements or inaccuracies in the financial position, performance, and cash flows of Ghani ChemWorld Limited for the reported period. The financial statements are deemed to fairly present the company's financial standing as of February 20, 2025.